SCHEMBL3240202

SCHEMBL3240202

CCc1ccc2c(CC)cccc2c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.55
CYP2A6 P11509 1/20 0.55
KIF11 P52732 1/20 0.42
MAPK1 P28482 2/20 0.41
MC5R P33032 1/20 0.41
GABRA1 P14867 2/20 0.40
GABRB2 P47870 2/20 0.40
NPC1 O15118 1/20 0.40
ALDH1A1 P00352 1/20 0.40
LMNA P02545 1/20 0.40
MAPT P10636 1/20 0.40
RAB9A P51151 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
GAA P10253 1/20 0.38
SIGMAR1 Q99720 1/20 0.38
DAO P14920 2/20 0.38
AKR1C3 P42330 1/20 0.38
AKR1C2 P52895 1/20 0.38
DDO Q99489 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30688302 0.87 CYP1A2 (0.50) CYP1A2CYP2A6KIF11MAPK1MC5R
SCHEMBL15345818 0.87 CYP1A2 (0.50) CYP1A2CYP2A6KIF11MAPK1MC5R
SCHEMBL29101380 0.87 CYP1A2 (0.50) CYP1A2CYP2A6KIF11MAPK1MC5R
SCHEMBL15345427 0.87 CSNK2A2 (0.47) CYP1A2CYP2A6MAPK1MC5R
SCHEMBL23070782 0.85 CYP1A2 (0.53) CYP1A2CYP2A6KIF11MAPK1MC5R
SCHEMBL49863 0.85 CYP1A2 (0.69) CYP1A2CYP2A6MAPK1MC5RGAA
SCHEMBL6889822 0.85 CYP1A2 (0.58) CYP1A2CYP2A6MAPK1MC5RGABRA1
SCHEMBL3238625 0.84 CYP1A2 (0.55) CYP1A2CYP2A6MAPK1MC5RGABRA1
SCHEMBL5538295 0.82 CYP1A2 (0.53) CYP1A2CYP2A6KIF11MAPK1NPC1
SCHEMBL7752839 0.80 CYP1A2 (0.59) CYP1A2CYP2A6KIF11MAPK1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2210907-B1 POLYFUNCTIONAL DIMETHYLNAPHTHALENE FORMALDEHYDE RESIN, AND PROCESS FOR PRODUCTION THEREOF MITSUBISHI GAS CHEMICAL CO (JP) 2017-03-08 EP disclosed
CN-104628774-A Method for preparing alkane base containing phosphine bridge dichloropentate cyclooctane PTG ADVANCED CATALYST CO LTD 2015-05-20 CN disclosed
US-8648152-B2 Polyfunctional dimethylnaphthalene formaldehyde resin, and process for production thereof MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2014-02-11 US disclosed
CN-101861344-B Polyfunctional dimethylnaphthalene formaldehyde resin, and process for production thereof MITSUBISHI GAS CHEMICAL CO 2013-08-28 CN disclosed
US-20100324255-A1 POLYFUNCTIONAL DIMETHYLNAPHTHALENE FORMALDEHYDE RESIN, AND PROCESS FOR PRODUCTION THEREOF MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2010-12-23 US disclosed
CN-101861344-A Polyfunctional dimethylnaphthalene formaldehyde resin, and process for production thereof MITSUBISHI GAS CHEMICAL CO 2010-10-13 CN disclosed
EP-2210907-A1 POLYFUNCTIONAL DIMETHYLNAPHTHALENE FORMALDEHYDE RESIN, AND PROCESS FOR PRODUCTION THEREOF Mitsubishi Gas Chemical Company, Inc. (JP) 2010-07-28 EP disclosed
US-7569694-B2 Coumarin compound, material for light emitting device and organic electroluminescent device CHISSO CORPORATION (JP) 2009-08-04 US disclosed
US-20070176544-A1 Coumarin compound, material for light emitting device and organic electroluminescent device JNC CORPORATION (JP) 2007-08-02 US disclosed
EP-0908437-B1 Method for separating alkylnaphthalene KOBE STEEL LTD (JP) 2002-06-05 EP disclosed
EP-0710684-B1 Preparation process of polyhydroxycarboxylic acid MITSUI CHEMICALS INC (JP) 2001-01-31 EP disclosed
US-6153808-A Method for separating alkylnaphthalene KABUSHIKI KAISHA KOBE SEIKO SHO (JP) 2000-11-28 US disclosed
EP-0908437-A1 Method for separating alkylnaphthalene KABUSHIKI KAISHA KOBE SEIKO SHO also known as Kobe Steel Ltd. (JP) 1999-04-14 EP disclosed
US-5770683-A Preparation process of polyhydroxycarboxylic acid MITSUI TOATSU CHEMICALS, INC. (JP) 1998-06-23 US disclosed
EP-0710684-A2 Preparation process of polyhydroxycarboxylic acid MITSUI TOATSU CHEMICALS, Inc. (JP) 1996-05-08 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070176544-A1 Coumarin compound, material for light emitting device and organic electroluminescent device TRPA1, CYP3A4, UGT1A10 CYP1A2 18/4885CYP2A6 294/4885KIF11 1655/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.